OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System
Share this article Share this article YOKNEAM, Israel, Jan. 25, 2021 /PRNewswire/ -- OrthoSpin Ltd. ("OrthoSpin"), announced today that it received regulatory clearance from the United States Food and Drug Administration (FDA) for its second generation, robotic, digitally enabled external fixation system for orthopedic treatments. OrthoSpin’s FDA-cleared Generation 2 robotic system enables automation of external fixation orthopedic treatments (credit: OrthoSpin). External fixation devices are a common treatment choice for bone lengthening, setting complex fractures, and correcting deformiti...
Source: prnewswire.com